Cas3 Biotherapeutics, Inc. is a biotechnology company discovering and developing oncology therapies using CRISPR-Cas3 to genotypically target tumor-specific mutations and destroy cancer cells. Our proprietary Type I(E) CRISPR-Cas3 system precisely targets mutations as small as a single base and disrupts large segments of DNA to disrupt essential genes.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Cambridge, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Oncology, CRISPR, Gene Editing.
- HQ
- Cambridge, MA
Cas3 Biotherapeutics Questions
Cas3 Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/cas3bio
Cas3 Biotherapeutics has
3 employees.
View email and phone details for 3
employees at Cas3 Biotherapeutics.
Cas3 Biotherapeutics's industry is
Biotechnology Research
Cas3 Biotherapeutics's top competitors are
Scpharmaceuticals,
Ucr,
Loopin,
Btig,
Ai Proteins,
Editas Medicine,
Ultivue By Vizgen,
Vizgen,
Biolink Therapeutics,
Cidara Therapeutics.
Cas3 Biotherapeutics's categories are Biotechnology Research
Cas3 Biotherapeutics's founding year is 2024
